Table 1.
LncRNA | Binding Protein | Regulatory Protein | Cancer Type | Reference |
---|---|---|---|---|
TROJAN | NKRF | RELA, CDK2 | Breast cancer | [23] |
LINC01585 | NONO | CREB | Breast cancer | [24] |
ZEB1-AS1 | HuR | ZEB1 | Breast cancer | [25] |
OCC-1 * | HuR | hnRNPK, EIF4E | Colorectal cancer | [27] |
LINC ROR | hnRNP1 | c-Myc | Colorectal cancer | [28] |
SNHG6 | EZH2 | p21 | Colorectal cancer | [29] |
LINC00114 | EZH2/DNMT1 | NUP214 | Colorectal cancer | [30] |
PCAT1 | FKBP51 | NF-κB, AKT | Prostate cancer | [31] |
LOC283070 | PHB2 | AR | Prostate cancer | [32] |
GAS5 * | E2F1 | P27Kip1 | Prostate cancer | [33] |
TINCR | STAU1 | CDKN2B | Gastric cancer | [35] |
FEZF1-AS1 | LSD1 | p21 | Gastric cancer | [36] |
LINC00152 | EGFR | PI3K/AKT | Gastric cancer | [38] |
SOX2OT | FUS | CCND1/p27 | Pancreatic cancer | [40] |
LINC01197 * | B-catenin | WNT/β-catenin | Pancreatic cancer | [42] |
LINC00037 | EGFR | EGFR | Renal cancer | [43] |
LINC02535 | PCBP2 | RRM1 | Cervical cancer | [44] |
PLAC2 | STAT1 | RPL36, CDK2 | Glioma | [45] |
SLNCR | AR/EGR1 | p21 | Melanoma | [46] |
TUG1 * | EZH2/EED | CELF1 | Lung cancer | [47] |
DLEU2 | HBx | PRC2 | Liver cancer | [48] |
* anti-cancer effect.